Research Impact

h-index

N/A

Research impact score

Publications

Total publications

Trial Results

Published trial results

Citations

Total citations

Drug Portfolio

MIXED(3)

3 unique interventions1 categories

Analytics

Trial Phases

Phase 11

Trial Status

Other1

Role Distribution

Principal Investigator1

PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT05005299Phase 1Unknown

Venetoclax in Combination With Non-myeloablative Conditioning Allogeneic Haematopoietic Stem Cell Transplantation

Leukemia, Lymphoblastic, Acute, L1Leukemia, Lymphoblastic, Acute, L2Leukemia, Myeloid, Acute+3 more

PrincipalinvestigatorStart date: 2022-06-08

Research Network

Collaboration Network

1 collaborators·0 connections

Network Legend

KOL

Current Investigator

High-influence Collaborator

Collaborator

Click: view details

Double-click: go to profile

Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Leukemia, Lymphocytic, Acute, L11 Leukemia, Lymphocytic, Acute, L21 Leukemia, Myeloid, Acute1 Myelodysplastic Syndromes1 Lymphoma, Non-Hodgkin1 Multiple Myeloma1

Affiliations

Melbourne Health

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

24 trials

Shared therapeutic areas:

Multiple MyelomaLeukemia, Myeloid, AcuteLymphoma, Non-Hodgkin+1 more

Similarity Score20%

Arnon Nagler, MD

Chaim Sheba Medical Center

12 trials

Shared therapeutic areas:

Multiple MyelomaLymphoma, Non-HodgkinLeukemia, Myeloid, Acute+1 more

Similarity Score20%

Yves Beguin, MD, PhD

CHU-ULg

7 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteLymphoma, Non-HodgkinMultiple Myeloma+1 more

Similarity Score20%

Areej El-Jawahri, MD

Massachusetts General Hospital

21 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteMultiple MyelomaMyelodysplastic Syndromes

Similarity Score15%

Beata Holkova, MD

Massey Cancer Center

3 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteMyelodysplastic Syndromes

Similarity Score10%

Jorge Cortes, MD

M.D. Anderson Cancer Center

24 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteMyelodysplastic Syndromes

Similarity Score10%

Stanislaw R. Burzynski, MD, PhD

Burzynski Research Institute

62 trials

Shared therapeutic areas:

Lymphoma, Non-HodgkinMultiple Myeloma

Similarity Score10%

Qifa Liu

Nanfang Hospital, Southern Medical University

33 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteMyelodysplastic Syndromes

Similarity Score10%

John D. Hainsworth, MD

SCRI Development Innovations, LLC

26 trials

Shared therapeutic areas:

Lymphoma, Non-HodgkinMultiple Myeloma

Similarity Score10%

Courtney DiNardo, MD

M.D. Anderson Cancer Center

16 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteMyelodysplastic Syndromes

Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT05005299Phase 1PrincipalInvestigator

Venetoclax in Combination With Non-myeloablative Conditioning Allogeneic Haematopoietic Stem Cell Transplantation

Leukemia, Lymphoblastic, Acute, L1Leukemia, Lymphoblastic, Acute, L2Leukemia, Myeloid, Acute+3 more

Unknown

All 1 trials loaded